Go to deals
Healthcare

IceCure Medical has issued bonds worth US$5.7 million

IceCure Medical Ltd. has completed a fundraising to refinance and develop the company.

IceCure is an Israeli medical device company that has developed technology to eliminate benign and cancerous tumors in the breast and other parts of the body by freezing the tumor during treatment in a clinic and without surgery, using the ProSense system developed at the Elisha Private Hospital in Haifa.

Oaklins’ team in Israel advised IceCure Medical Ltd. and acted as the leader of the distributors’ consortium.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Ruben  Eblagon

Ruben Eblagon

Principal

Tel Aviv, Israel
Oaklins Rosario
 Boaz  Levi

Boaz Levi

Partner

Tel Aviv, Israel
Oaklins Rosario
 Olga  Geyber

Olga Geyber

Support

Tel Aviv, Israel
Oaklins Rosario

Related deals

Dental Holding has been acquired by Advantage Partners
Healthcare

Dental Holding has been acquired by Advantage Partners

Noritsu Koki Co., Ltd. has sold Dental Holding Inc. to Advantage Partners Inc.

Learn more
GeneTech Inc. has been acquired by Eurofins
Healthcare

GeneTech Inc. has been acquired by Eurofins

Noritsu Koki Co., Ltd. has sold GeneTech Inc. to Eurofins Clinical Testing Holding Lux S.à r.l.

Learn more
MediCa group has been acquired by Repharm
Healthcare

MediCa group has been acquired by Repharm

CGP Management has sold MediCa group, the largest private provider of healthcare services in Lithuania, to Repharm.

Learn more